All In Biotech

Free tool

FAERS Monitor: Naprelan

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 020353 or its brand name (Naprelan, Naproxen Sodium). Reports on generic versions are filed under their own applications.

Reports

13,985

Serious

10,751

77% of reports

Hospitalization

6,092

Death reported

3,931

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • drug ineffective3,011
  • fatigue2,757
  • off label use2,620
  • pain2,616
  • rash2,391
  • arthralgia2,341
  • diarrhoea2,328
  • vomiting2,269
  • condition aggravated2,199
  • joint swelling2,197
  • synovitis2,148
  • fibromyalgia2,142
  • rheumatoid arthritis2,139
  • dizziness2,102
  • abdominal discomfort2,084

Reports by year received

View as table
YearReports
2004115
2005159
200673
200757
2008171
2009123
2010151
2011374
20121,169
2013248
2014243
2015318
2016498
2017512
2018536
2019769
2020744
2021674
20221,002
20231,153
20242,036
20252,056
2026803

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,040,174 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
synovitisSignal2,148203.2194.9380,945
fibromyalgiaSignal2,142145.2139.4279,968
rheumatoid arthritisSignal2,13928.927.756,724
joint swellingSignal2,19727.926.856,158
abdominal discomfortSignal2,08418.918.235,167
condition aggravatedSignal2,19910.910.520,017
arthralgiaSignal2,3418.58.215,731
rashSignal2,3918.38.015,558
vomitingSignal2,2697.37.012,525
painSignal2,6166.46.212,293
dizzinessSignal2,1026.46.19,681
diarrhoeaSignal2,3285.45.28,668
fatigueSignal2,7575.35.210,061
off label useSignal2,6204.54.47,443
drug ineffectiveSignal3,0113.43.35,549

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.